Attention-deficit/hyperactivity disorder: Are we medicating for social disadvantage? (For)

16Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The diagnosis of attention-deficit/hyperactivity disorder (ADHD) is based on well defined criteria, which describe a number of symptoms. It is important to consider the context of the symptoms, in terms of the influence of the child's family and school. Although stimulant medications benefit selected children they may not benefit all children with symptoms of ADHD. The incidence of ADHD increases with social disadvantage. There is a potential danger of using stimulant medication alone to treat children with complex psychosocial problems, associated with social disadvantage, including Aboriginal children. We desperately need better training in the management of ADHD and better access to child psychiatrists. © 2006 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Cite

CITATION STYLE

APA

Isaacs, D. (2006, September). Attention-deficit/hyperactivity disorder: Are we medicating for social disadvantage? (For). Journal of Paediatrics and Child Health. https://doi.org/10.1111/j.1440-1754.2006.00919.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free